GNTANasdaqBiological Products, (No Diagnostic Substances)
Genenta Science S.p.A.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026
$0.66−0.02 (-2.40%)
Close on Oct 19, 2026
Community
Notes and questions about Genenta Science S.p.A. from other investors
No posts about GNTA yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.